The burnout crisis in healthcare continues to escalate.
Peptides are everywhere—from longevity clinics to social media. But not everyone is qualified to give advice. Here’s what to know before you trust the trend.
The 49ers investigated a conspiracy theory—not to validate it, but to remove doubt. A lesson for leaders navigating uncertainty, risk and decisionmaking.
New JAMA studies examine whether routine colonoscopies and low‑dose thyroid drugs benefit older adults, raising questions about risks, costs and continued use.
Nearly 200 blood proteins rise and fall across the menstrual cycle, enabling a test that pinpoints cycle day and links it to risks like fibroids and heavy bleeding.
Eliminating flu and COVID-19 vaccine requirements threatens our military preparedness and goes against data. Will Hegseth go after other vaccine-preventable infections next?
With conflicts escalating in many parts of the world, we’re seeing an upsurge in malaria cases and deaths. In some cases, the disease kills more people than the fighting.
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
Mary Minno launches early-stage startup accelerator program, Treehub, and an early-stage firm, AI Health Fund, aimed at backing startups working at the intersection of healthcare and AI.
An overactive immune switch in the placenta may drive preeclampsia; blocking it in models reverses key disease pathways, pointing toward targeted therapies.